Philip D. Home - Translational and Clinical Research Institute, Newcastle University

基本信息

浏览量：110

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 228 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

An Overview of Insulin Therapy for the Non-Specialist

Philip D Home

Diabetes, obesity & metabolism (2025): 3-15

引用0浏览0WOS引用

1880-LB: Efficacy and Safety of Iglarlixi Vs. IDegAsp in Non-Asian People with Type 2 Diabetes Inadequately Controlled with Basal Insulin—A Systemic Literature Review and Network Meta-analysis

PHILIP HOME,FELIPE LAUAND,KHIER DJABALLAH,FRANCOIS BOURHIS,XUAN LI,KHADIJA HAFIDH,ROOPA MEHTA, KHADRA FARAOUN, INAN ANAFOROGLU,MIR-MASOUD POURRAHMAT

Diabetes（2024）

引用0浏览0引用

Efficacy and Safety of Iglarlixi Vs. IDegAsp in Non-Asian People with Type 2 Diabetes Inadequately Controlled with Basal Insulin-A Systemic Literature Review and Network Meta-analysis

Philip Home,Felipe Lauand,Khier Djaballah,Francois Bourhis,Xuan Li,Khadija Hafidh,Roopa Mehta, Khadra Faraoun, Inan Anaforoglu,Mir-Masoud Pourrahmat

DIABETES (2024)

引用0浏览0WOS引用

Findings for Iglarlixi Versus BIAsp 30 Confirmed in Groups of People with Type 2 Diabetes with Different Biomedical Characteristics

Philip D. Home,Rory J. McCrimmon,Julio Rosenstock,Matthias Bluher,Katrin Pegelow,Lydie Melas-Melt,Khier Djaballah,Francesco Giorgino

DIABETES OBESITY & METABOLISM（2023）

引用5浏览0WOS引用

Understanding Biosimilar Insulins - Development, Manufacturing, and Clinical Trials

Lutz Heinemann,Melanie Davies,Philip Home,Thomas Forst,Tina Vilsboll,Oliver Schnell

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY（2023）

引用3浏览0WOS引用

Therapieintensivierung Bei Mit Basalunterstützter Oraler Therapie (BOT) Behandeltem Typ-2-Diabetes: Explorative Analyse Der SoliMix-Studie Nach Alter, Diabetesdauer Und Nierenfunktion Zu Studienbeginn

Philip D. Home,Julio Rosenstock,Francesco Giorgino,Matthias Blüher,Thorsten Siegmund,Khier Djaballah,Katrin Pegelow,Lydie Melas-Melt,Rory J. McCrimmon

Diabetologie und Stoffwechsel Vielfalt &amp Individualität - Diabetes neu denkenwwwdiabeteskongressd...（2023）

引用0浏览0引用

Insulin Biobetters and Biosimilars in Clinical Practice

Philip Home

JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGHno. 2 (2023): 147-155

引用1浏览0WOS引用

Therapieintensivierung Bei Mit Basalunterstützter Oraler Therapie (BOT) Behandeltem Typ-2-Diabetes: Explorative Analyse Der SoliMix-Studie Nach HbA1c, Insulindosis Und BMI Zu Studienbeginn

Philip D. Home,Rory J. McCrimmon,Julio Rosenstock,Matthias Blüher,Thorsten Siegmund,Katrin Pegelow,Lydie Melas-Melt,Khier Djaballah,Francesco Giorgino

Diabetologie und Stoffwechsel Vielfalt &amp Individualität - Diabetes neu denkenwwwdiabeteskongressde (2023)

引用0浏览0引用

Making Sense of Weekly Insulins

Philip Home

The lancet Diabetes & endocrinology（2023）

引用1浏览0WOS引用

Hypoglycaemia Events with Iglarlixi Versus Premix Biphasic Insulin Aspart 30 (biasp 30) in People with Type 2 Diabetes Advancing from Basal Insulin: an Analysis of the SoliMix Trial

Rory J. McCrimmon,Philip Home,Alice Cheng,Francesco Giorgino,Vivian Fonseca,Elisabeth Souhami,Agustina Alvarez,Pascaline Picard,Julio Rosenstock

Diabetes, obesity and metabolism（2022）

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn